Ensysce Biosciences, Inc. has entered into a Securities Purchase Agreement to sell approximately 2.49 million shares of common stock at $0.47 each, raising about $1.67 million, and will also issue warrants for additional shares, with net proceeds expected to be around $4.5 million for development programs and working capital.